Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sudhanshu Mulay"'
Publikováno v:
Case Reports in Hematology, Vol 2020 (2020)
Primary bone lymphoma (PBL) is a subtype of lymphoma that exclusively affects skeletal tissue. Despite the relatively common involvement of skeletal structures as a manifestation of non-Hodgkin’s lymphoma (NHL), primary and exclusive involvement of
Externí odkaz:
https://doaj.org/article/d3d398a8c8ff49bda709482c9b7c851b
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1549-1552
Introduction Bortezomib is a proteasome inhibitor used in the treatment of multiple myeloma, Waldenström’s macroglobulinemia, mantle cell lymphoma. The most reported adverse effects include fatigue, thrombocytopenia, gastrointestinal symptoms, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad3e57d3b32c7e361fdfd1a03da7fbf2
https://doi.org/10.1177/1078155220904153
https://doi.org/10.1177/1078155220904153
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2020 (2020)
Case Reports in Hematology, Vol 2020 (2020)
Primary bone lymphoma (PBL) is a subtype of lymphoma that exclusively affects skeletal tissue. Despite the relatively common involvement of skeletal structures as a manifestation of non-Hodgkin’s lymphoma (NHL), primary and exclusive involvement of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::058728a9963780c709d011739642d0d8
http://europepmc.org/articles/PMC7171650
http://europepmc.org/articles/PMC7171650
Supplemental material, OPP904153 Supplemental Material for Bortezomib-induced motor neuropathy: A case report by Meghana Singh, Vinay M Thomas and Sudhanshu Mulay in Journal of Oncology Pharmacy Practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17483d5b8b6020fdffa3ab655b7e4efa
Autor:
Michelle A. Elliott, Sandra C. Bryant, Justin D. Kreuter, William J. Hogan, Sudhanshu Mulay, Dennis A. Gastineau, Jeffrey L. Winters
Publikováno v:
Journal of Clinical Apheresis. 30:147-153
Transplant-associated thrombotic microangiopathy (TA-TMA) is a rare clinical syndrome associated with significant mortality. Although the use of plasma exchange (PE) in TA-TMA continues to be explored, evidence for its efficacy is debated. We perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d694f99d78f1ea5c1b7ebda29b5a8fea
https://doi.org/10.1002/jca.21352
https://doi.org/10.1002/jca.21352
Publikováno v:
Leukemia & Lymphoma. 52:341-343
Hemophagocytic lymphohistiocytosis (HLH), also called hemophagocytic syndrome, is an aggressive hyperinflammatory condition characterized by prolonged fever, cytopenias, hepatosplenomegaly, and hem...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41455df36a704c2dd898eb02ac87ab82
https://doi.org/10.3109/10428194.2010.534209
https://doi.org/10.3109/10428194.2010.534209
Autor:
Sudhanshu, Mulay, Justin D, Kreuter, Sandra C, Bryant, Michelle A, Elliott, William J, Hogan, Jeffrey L, Winters, Dennis A, Gastineau
Publikováno v:
Journal of clinical apheresis. 30(3)
Transplant-associated thrombotic microangiopathy (TA-TMA) is a rare clinical syndrome associated with significant mortality. Although the use of plasma exchange (PE) in TA-TMA continues to be explored, evidence for its efficacy is debated. We perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::117de709742486cdba707dbc8c3b9044
https://pubmed.ncbi.nlm.nih.gov/25230249
https://pubmed.ncbi.nlm.nih.gov/25230249
Autor:
Dengfeng Cheng, Erik Lovria, Jesse Schoonmaker, Siddhartha Mukherjee, Gary S. Stein, Thomas K. Barthel, Sudhanshu Mulay, Julie C. Liu, Mary L. Bouxsein, Jane B. Lian, Marci D. Jones, David C. Ayers, Sadiq Hussain
Purpose: The incidence of bone metastasis in advanced breast cancer (BrCa) exceeds 70%. Bortezomib, a proteasome inhibitor used for the treatment of multiple myeloma, also promotes bone formation. We tested the hypothesis that proteasome inhibitors c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26b3213d069601e898a2cf6d963041f9
https://europepmc.org/articles/PMC2955762/
https://europepmc.org/articles/PMC2955762/